Immune checkpoint modulating T cells and NK cells response to Mycobacterium tuberculosis infection

Area of Science:

• Immunology
• Infectious Diseases
• Cancer Research

Background:

• Subversive mechanisms, including altered immune receptor expression, drive chronic infectious diseases and cancer.
• Immune checkpoint inhibitors show promise in cancer therapy, but their role in infectious diseases like tuberculosis is less understood.
• The impact of Mycobacterium tuberculosis (Mtb) infection on immune checkpoint molecules in natural killer (NK) cells remains poorly characterized.

Purpose of the Study:

• To review current knowledge on immune checkpoint expression in NK cells during Mtb infection.
• To investigate how Mtb infection alters NK cell effector functions, including cytotoxicity and cytokine secretion.
• To explore the potential of immune checkpoint inhibitors as a therapeutic strategy for tuberculosis.

Main Methods:

• Literature review focusing on studies examining NK cell immune checkpoints in the context of Mtb infection.
• Analysis of existing data on NK cell-mediated cytotoxicity and cytokine production following Mtb exposure.
• Comparison of immune characteristics between T cells and NK cells in response to Mtb.

Main Results:

• Mtb infection influences the expression of immune checkpoints on NK cells, potentially impairing their function.
• Altered NK cell activity may contribute to disease progression in tuberculosis.
• Similarities between T cell and NK cell responses to Mtb suggest shared regulatory pathways.

Conclusions:

• Understanding NK cell immune checkpoint modulation during Mtb infection is critical for tuberculosis pathogenesis.
• NK cells play a significant role in the innate immune response to tuberculosis.
• Targeting NK cell immune checkpoints could offer a novel immunotherapeutic approach for treating tuberculosis.